BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 19455636)

  • 21. Extension of the celiac intestinal antibody (CIA) pattern through eight antibody assessments in fecal supernatants from patients with celiac disease.
    Di Tola M; Marino M; Casale R; Di Battista V; Borghini R; Picarelli A
    Immunobiology; 2016 Jan; 221(1):63-9. PubMed ID: 26271834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of Antibody-Based Strategies for Diagnosis of Pediatric Celiac Disease Without Biopsy.
    Wolf J; Petroff D; Richter T; Auth MKH; Uhlig HH; Laass MW; Lauenstein P; Krahl A; Händel N; de Laffolie J; Hauer AC; Kehler T; Flemming G; Schmidt F; Rodrigues A; Hasenclever D; Mothes T
    Gastroenterology; 2017 Aug; 153(2):410-419.e17. PubMed ID: 28461188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of deamidated gliadin peptide antibodies to monitor diet compliance in childhood celiac disease.
    Monzani A; Rapa A; Fonio P; Tognato E; Panigati L; Oderda G
    J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):55-60. PubMed ID: 21694536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients.
    Comino I; Fernández-Bañares F; Esteve M; Ortigosa L; Castillejo G; Fambuena B; Ribes-Koninckx C; Sierra C; Rodríguez-Herrera A; Salazar JC; Caunedo Á; Marugán-Miguelsanz JM; Garrote JA; Vivas S; Lo Iacono O; Nuñez A; Vaquero L; Vegas AM; Crespo L; Fernández-Salazar L; Arranz E; Jiménez-García VA; Antonio Montes-Cano M; Espín B; Galera A; Valverde J; Girón FJ; Bolonio M; Millán A; Cerezo FM; Guajardo C; Alberto JR; Rosinach M; Segura V; León F; Marinich J; Muñoz-Suano A; Romero-Gómez M; Cebolla Á; Sousa C
    Am J Gastroenterol; 2016 Oct; 111(10):1456-1465. PubMed ID: 27644734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue transglutaminase antibodies in celiac disease, comparison of an enzyme linked immunosorbent assay and a dot blot assay.
    Mankaï A; Sakly W; Landolsi H; Gueddah L; Sriha B; Ayadi A; Sfar MT; Skandrani K; Harbi A; Essoussi AS; Korbi S; Fabien N; Jeddi M; Ghedira I
    Pathol Biol (Paris); 2005 May; 53(4):204-9. PubMed ID: 15850953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a microsphere-based flow cytometric assay for diagnosis of celiac disease.
    Yiannaki EE; Zintzaras E; Analatos A; Theodoridou C; Dalekos GN; Germenis AE
    J Immunoassay Immunochem; 2004; 25(4):345-57. PubMed ID: 15552589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Significance of a method for determination of deamidated gliadin peptide in the diagnosis of celiac disease].
    Sabelnikova EA; Parfenov AI; Krums LM; Gudkova RB; Sagynbaeva VE; Bykova SV
    Ter Arkh; 2014; 86(2):39-43. PubMed ID: 24772506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serologic screening for celiac disease in children: a comparison between established assays and tests with deamidated gliadin-derived peptides plus conjugates for both IgA and IgG antibodies.
    Aberg AK; Olcén P
    APMIS; 2009 Nov; 117(11):808-13. PubMed ID: 19845531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serologic assay for diagnosis of celiac disease based on a patient-derived monoclonal antigliadin antibody.
    Steinsbø Ø; Dørum S; Lundin KE; Sollid LM
    Gastroenterology; 2015 Nov; 149(6):1530-1540.e3. PubMed ID: 26208894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies against neo-epitope of microbial and human transglutaminase complexes as biomarkers of childhood celiac disease.
    Agardh D; Matthias T; Wusterhausen P; Neidhöfer S; Heller A; Lerner A
    Clin Exp Immunol; 2020 Mar; 199(3):294-302. PubMed ID: 31663117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of Deamidated Gliadin Antibodies in the Follow-Up of Treated Celiac Disease.
    de Chaisemartin L; Meatchi T; Malamut G; Fernani-Oukil F; Hosking F; Rault D; Bellery F; Cellier C; Dragon-Durey MA
    PLoS One; 2015; 10(8):e0136745. PubMed ID: 26322980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel assay for detecting celiac disease-associated autoantibodies in dermatitis herpetiformis using deamidated gliadin-analogous fusion peptides.
    Kasperkiewicz M; Dähnrich C; Probst C; Komorowski L; Stöcker W; Schlumberger W; Zillikens D; Rose C
    J Am Acad Dermatol; 2012 Apr; 66(4):583-8. PubMed ID: 21840083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Predictive value of serological tests in the diagnosis of celiac disease].
    Carroccio A; Di Prima L; Falci C; Le Moli C; Soresi M; Montalto G; Notarbartolo A
    Ann Ital Med Int; 2002; 17(2):102-7. PubMed ID: 12150043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgA antibodies against deamidated gliadin peptides in patients with chronic liver diseases.
    Gatselis NK; Zachou K; Norman GL; Tzellas G; Speletas M; Gabeta S; Germenis A; Koukoulis GK; Dalekos GN
    Clin Chim Acta; 2012 Oct; 413(19-20):1683-8. PubMed ID: 22643316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a point-of-care test based on deamidated gliadin peptides for celiac disease screening in a large pediatric population.
    Bienvenu F; Besson Duvanel C; Seignovert C; Rouzaire P; Lachaux A; Bienvenu J
    Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1418-23. PubMed ID: 23032795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating diagnostic accuracy of anti-tissue Transglutaminase IgA antibodies as first screening for Celiac Disease in very young children.
    Frulio G; Polimeno A; Palmieri D; Fumi M; Auricchio R; Piccolo E; Carandente Giarrusso P
    Clin Chim Acta; 2015 Jun; 446():237-40. PubMed ID: 25944768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early diagnosis of celiac disease in IgA deficient children: contribution of a point-of-care test.
    Bienvenu F; Anghel SI; Besson Duvanel C; Guillemaud J; Garnier L; Renosi F; Lachaux A; Bienvenu J
    BMC Gastroenterol; 2014 Nov; 14():186. PubMed ID: 25376178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relevance of anti-tissue transglutaminase antibodies in coeliac disease diagnosis].
    Lepers S; Soula F; Fily S; Fontaine E; Vuye S; Colombel JF; Guimber D; Prin L; Dubucquoi S
    Ann Biol Clin (Paris); 2003; 61(3):337-43. PubMed ID: 12805013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies to gliadin, endomysium, and tissue transglutaminase for the diagnosis of celiac disease.
    Vitoria JC; Arrieta A; Arranz C; Ayesta A; Sojo A; Maruri N; García-Masdevall MD
    J Pediatr Gastroenterol Nutr; 1999 Nov; 29(5):571-4. PubMed ID: 10554125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of anti-transglutaminase (anti-tTG), anti-gliadin, and anti-endomysium serum antibodies in diagnosing celiac disease: a comparison of four different commercial kits for anti-tTG determination.
    Basso D; Gallo N; Guariso G; Pittoni M; Piva MG; Plebani M
    J Clin Lab Anal; 2001; 15(3):112-5. PubMed ID: 11344524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.